Total deal volume in the medical device industry contracted by about 13% in 2013, according to new analysis from audit shop PricewaterhouseCoopers.
Medtronic Inc. (NYSE:MDT) won CE Mark approval in the European for its percutaneous aortic valve replacement system, CoreValve.
The device is "the only transcatheter aortic valve available in the world that can treat – without surgery – patients with larger valve openings (up to 29mm)," according to a press release.
CoreValve is the largest transcatheter valve available, but can compress into a small delivery system to be deployed in the same delivery system as smaller CoreValve sizes.
Toshiba Medical Systems Corp. successfully completed its tender offer for the $273 million acquisition of Vital Images Inc. (NSDQ:VTAL).
At the end of the second offering period 12,253,984 shares were validly tendered, representing about 86.7 percent of Vital Image’s outstanding stock on a non-fully diluted basis and about 76.8 percent of the stock on a fully diluted basis.
Toshiba Medical Systems Corp. came one step closer the $273 million acquisition of Vital Images Inc. (NSDQ:VTAL) with the announcement that the initial tender offer period had expired.
A total of 11.9 million shares were tendered by expiration time, representing about 72 percent of Vital Images’ outstanding common stock on a fully diluted basis.
Vital Images Inc. (NSDQ:VTAL) posted fourth-quarter sales of $6.6 million for the three months ended Dec. 31, 2009, down 18.8 percent compared with $8.1 million during the same period in 2008. Net losses widened 63.2 percent to $630,000, compared with $386,000 during Q4 2008: